Cargando…
Emerging targets in gastroesophageal adenocarcinoma: what the future looks like
Gastroesophageal adenocarcinoma (GEA) is a heterogeneous disease with a poor prognosis. Chemotherapy has been the cornerstone in treating metastatic diseases. Recently, the introduction of immunotherapy demonstrated improved survival outcomes in localized and metastatic diseases. Beyond immunotherap...
Autores principales: | Petrillo, Angelica, Smyth, Elizabeth C., van Laarhoven, Hanneke W. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10184253/ https://www.ncbi.nlm.nih.gov/pubmed/37197225 http://dx.doi.org/10.1177/17588359231173177 |
Ejemplares similares
-
Immunotherapy for Gastroesophageal Cancer
por: Goode, Emily F., et al.
Publicado: (2016) -
This is what life with cancer looks like: exploring experiences of adolescent and young adults with cancer using two visual approaches
por: Bood, Zarah M., et al.
Publicado: (2022) -
Looking to the Future: Biomarkers in the Management of Pancreatic Adenocarcinoma
por: Spratlin, Jennifer L., et al.
Publicado: (2011) -
Radiology training. What good looks like, now and in the future
por: Harden, S.P., et al.
Publicado: (2022) -
HER2-targeted advanced metastatic gastric/gastroesophageal junction adenocarcinoma: treatment landscape and future perspectives
por: Li, Weiling, et al.
Publicado: (2022)